We found that the loss of SHMT2 results in a similar phenotype as the re-expression of K95Q which significantly decreased NADPH and increased ROS in colorectal cancer cells (Fig. 5d, e and Supplementary Fig. 4c, d). This evidence concerns the gene SHMT2 and colorectal cancer.